Matthew Pakizegee, PharmD, MS

Clinical Pathways GPS

Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease

03/16/2020

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD),...

...

03/16/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Engaging Patients in Care Through Greater Access to Medical Records and Clinical Pathways

04/16/2019

Kristin LaBounty Phillips , MPH;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Shay L. Ashline , PhD;

Matthew Pakizegee , PharmD, MS;

Without interoperability of medical records between health systems, patients are the best chance for the medical system to provide continuity of care when medical records from a different health system are difficult...

...

04/16/2019

Journal of Clinical Pathways